Fiscal Year 2024 KEY HIGHLIGHTS$273.9M net revenue27.5% comparable growth$203.6M adj. gross profit$40.3M Adj. Ebitda Results Events Latest Event Waldencast plc First Quarter Fiscal 2025 Earnings Call May 14, 2025 8:30 AM EDT Latest Event Waldencast plc Fourth Quarter Fiscal 2024 Earnings Call March 19, 2025 8:30 AM EDT All Events Press Releases Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™ March 19, 2026 Waldencast Reports Q4 2025 and FY 2025 Financial Results March 13, 2026 All Press Releases Stock Chart Stock Information Minimum 15 minutes delayed. Source: LSEG
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™ March 19, 2026